NCT04211922 2024-04-26
Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Terminated
Clinical Trials
3 trialsNCT06361589 2024-04-12
Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients
Sichuan Cancer Hospital and Research Institute
Recruiting
NCT02513667 2023-02-03
Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma
University of Texas Southwestern Medical Center
Phase 2 Terminated